JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
Zai Lab
ZLAB
$2.87B
| $2.81M | ﹤0.01% |
91,427
-111,745
| -55% | -$3.53M |
2020 Q1
11 quarters
|
|
3152
Radiant Logistics
RLGT
$437M
| $2.81M | ﹤0.01% |
551,229
-12,825
| -2% | -$71.9K |
2017 Q4
20 quarters
|
|
3153
Thryv Holdings
THRY
$61.3M
| $2.8M | ﹤0.01% |
147,585
-4,079
| -3% | -$79.6K |
2021 Q2
6 quarters
|
|
3154
GE HealthCare
GEHC
$29.3B
| $2.8M | ﹤0.01% |
+47,955
| New | +$2.76M |
2022 Q4
0 quarters
|
|
3155
PUT
Bilibili
BILI
$6.14B
| $2.79M | ﹤0.01% |
118,000
-100,000
| -46% | -$1.59M |
2021 Q4
4 quarters
|
|
3156
Clean Energy Fuels
CLNE
$344M
| $2.79M | ﹤0.01% |
537,530
+195,159
| +57% | +$1.2M |
2017 Q1
23 quarters
|
|
3157
Cogent Biosciences
COGT
$5.27B
| $2.79M | ﹤0.01% |
241,420
+12,578
| +5% | +$156K |
2020 Q4
8 quarters
|
|
3158
Fidelity Nasdaq Composite Index ETF
ONEQ
$11.2B
| $2.79M | ﹤0.01% |
+68,129
| New | +$2.91M |
2022 Q4
0 quarters
|
|
3159
Alight
ALIT
$239M
| $2.79M | ﹤0.01% |
16,688
+533
| +3% | +$88.8K |
2021 Q3
5 quarters
|
|
3160
CALL
Amgen
AMGN
$218B
| $2.78M | ﹤0.01% |
10,600
-28,700
| -73% | -$7.69M |
2014 Q3
33 quarters
|
|
|
RNAM
3161
DELISTED
Avidity Biosciences
RNAM
| $2.77M | ﹤0.01% |
124,918
+13,797
| +12% | +$206K |
2020 Q3
9 quarters
|
|
3162
CALL
Kimberly-Clark
KMB
$32.2B
| $2.76M | ﹤0.01% |
20,300
| – | – |
2022 Q1
3 quarters
|
|
|
VIA
3163
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $2.75M | ﹤0.01% |
107,663
-2,741
| -2% | -$86.2K |
2014 Q4
32 quarters
|
|
|
BSCO
3164
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
| $2.75M | ﹤0.01% |
134,011
+16,690
| +14% | +$341K |
2019 Q3
13 quarters
|
|
3165
iShares Core 10+ Year USD Bond ETF
ILTB
$581M
| $2.74M | ﹤0.01% |
53,867
-608
| -1% | -$30.8K |
2014 Q3
33 quarters
|
|
3166
Stem
STEM
$45.9M
| $2.74M | ﹤0.01% |
15,336
+1,802
| +13% | +$433K |
2021 Q1
7 quarters
|
|
3167
PUT
Boston Scientific
BSX
$61.1B
| $2.74M | ﹤0.01% |
59,200
| – | – |
2020 Q4
8 quarters
|
|
|
SRNE
3168
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.74M | ﹤0.01% |
3,091,177
+63,323
| +2% | +$84K |
2018 Q2
18 quarters
|
|
3169
Digital Turbine
APPS
$1.28B
| $2.74M | ﹤0.01% |
179,533
-5,379
| -3% | -$82.7K |
2018 Q3
17 quarters
|
|
3170
Compass Diversified
CODI
$829M
| $2.73M | ﹤0.01% |
149,761
+36,534
| +32% | +$686K |
2015 Q4
28 quarters
|
|
|
ALTR
3171
DELISTED
Altair Engineering Inc
ALTR
| $2.73M | ﹤0.01% |
59,954
-38,968
| -39% | -$1.82M |
2018 Q2
18 quarters
|
|
3172
Duolingo
DUOL
$6.93B
| $2.73M | ﹤0.01% |
38,339
-22,046
| -37% | -$1.72M |
2021 Q3
5 quarters
|
|
3173
CALL
Repligen
RGEN
$9.87B
| $2.73M | ﹤0.01% |
+16,100
| New | +$2.92M |
2022 Q4
0 quarters
|
|
|
CPE
3174
DELISTED
Callon Petroleum Company
CPE
| $2.72M | ﹤0.01% |
73,423
+6,123
| +9% | +$251K |
2015 Q1
31 quarters
|
|
3175
Ennis
EBF
$571M
| $2.72M | ﹤0.01% |
122,897
+7,708
| +7% | +$171K |
2013 Q2
38 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.